Strata Skin Sciences, Inc. 8-K Filing
Ticker: SSKN · Form: 8-K · Filed: Nov 13, 2025 · CIK: 1051514
| Field | Detail |
|---|---|
| Company | Strata Skin Sciences, Inc. (SSKN) |
| Form Type | 8-K |
| Filed Date | Nov 13, 2025 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Strata Skin Sciences, Inc. (ticker: SSKN) to the SEC on Nov 13, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ange on which registered Common Stock, $0.001 par value per share SSKN The NASDAQ).
How long is this filing?
Strata Skin Sciences, Inc.'s 8-K filing is 2 pages with approximately 677 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 677 words · 3 min read · ~2 pages · Grade level 9.4 · Accepted 2025-11-13 16:16:01
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share SSKN The NASDAQ
Filing Documents
- ef20058935_8k.htm (8-K) — 29KB
- ef20058935_ex99-1.htm (EX-99.1) — 338KB
- image00001.jpg (GRAPHIC) — 3KB
- 0001140361-25-041985.txt ( ) — 522KB
- sskn-20251113.xsd (EX-101.SCH) — 4KB
- sskn-20251113_lab.xml (EX-101.LAB) — 21KB
- sskn-20251113_pre.xml (EX-101.PRE) — 16KB
- ef20058935_8k_htm.xml (XML) — 4KB
02
Item 2.02. Results of Operations and Financial Condition. On November 13, 2025, STRATA Skin Sciences, Inc. (the "Company") issued a press release announcing its results of operations for the third fiscal quarter ended September 31, 2025 . The full text of such press release is furnished as Exhibit 99.1 to this report. The information set forth under this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
01
Item 7.01. Regulation FD Disclosure. On November 13, 2025, STRATA Skin Sciences, Inc. (the "Company") issued a press release announcing its results of operations for the third fiscal quarter ended September 31, 2025. The full text of such press release is furnished as Exhibit 99.1 to this report. The information set forth under this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. The following press release is furnished as an exhibit to this Current Report on Form 8-K pursuant to Item 2.02 and shall not be deemed to be "filed": 99.1 Press Release dated November 13, 2025 issued by STRATA Skin Sciences, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STRATA SKIN SCIENCES, INC. Date: November 13, 2025 By: /s/ John Gillings Chief Accounting Officer